A prospective randomized open-label crossover trial of regional citrate anticoagulation vs. anticoagulation free liver dialysis by the Molecular Adsorbents Recirculating System
Open Access
- 1 January 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 16 (1), R20
- https://doi.org/10.1186/cc11180
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The Coagulopathy of Chronic Liver DiseaseThe New England Journal of Medicine, 2011
- Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventionsExpert Review of Gastroenterology & Hepatology, 2011
- Regional anticoagulation with citrate: Expanding its indications*Critical Care Medicine, 2011
- Regional citrate anticoagulation in patients with liver failure supported by a molecular adsorbent recirculating system*Critical Care Medicine, 2011
- Early features of acute-on-chronic alcoholic liver failure: a prospective cohort studyGut, 2010
- Albumin Dialysis in Critically Ill Patients: Use Versus Omission of Intradialytic HeparinArtificial Organs, 2008
- Thromboelastography used to assess coagulation during treatment with molecular adsorbent recirculating systemClinical Transplantation, 2004
- Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patientsCritical Care Medicine, 2003
- Extracorporeal Detoxification Using the Molecular Adsorbent Recirculating System for Critically Ill Patients with Liver FailureJournal of the American Society of Nephrology, 2001
- Compensated cirrhosis: Natural history and prognostic factorsHepatology, 1987